Would the initial public offering of Breath of Life International be the most explosive IPO when the company finally lists on the TSX? Israel’s largest medical cannabis producer is known more as BOL Pharma in its home country. You shouldn’t miss on out on this marijuana IPO, as the company could be the global leader in medical cannabis.
As of July 17, 2019, there are about 22 companies that have filed for listing on the various stock exchanges in Canada. The businesses of the companies intending to go public vary. There are cannabis and hemp cultivators, payment processors, and specialty financing, among others.
But among all of the new applicants, Breath of Life’s IPO is highly anticipated.
Middle East’s pride
Breath of Life is a veteran cannabis grower, although 85 years ago, the company was growing avocado and peaches in Israel. BOL is the prime mover of cannabis in Israel. It’s the first company in the country to receive the licence to cultivate medical marijuana back in 2008.
Today, BOL is a vertically integrated company in the medical cannabis and cannabinoid-based pharmaceutical industries. Its operations span every stage of the value chain. BOL leads the way in cultivation, production, extraction, formulation, and product development. It does product research and testing, too.
BOL carries a lot of advantages. The favourable climate conditions, regulations, low energy footprint, and labour cost in Israel give BOL low-cost structure production capabilities.
Some of BOL’s focus areas are cannabinoid extracts and APIs (active pharmaceutical ingredients). The company is heavy on research development for the discovery of other cannabinoids and formulations in combination with innovative pharmaceutical delivery solutions.
BOL’s new centre is quite impressive. Its IMC GMP-certified facility has a 35,000-square-foot plant and an 8,000-square-foot storage room plus 30,000 square feet of grow rooms and labs. To top it, BOL has a million square feet of cultivation fields.
Full government support
BOL is fully supported by the Israeli government, as the country hopes to partake of the potential US$33 billion global market. Israel is aiming to be the world’s third-biggest exporter of medical cannabis after Canada and the Netherlands.
The Middle Eastern country estimate foreign sales to reach US$1.1 billion annually. That is achievable through BOL’s medical marijuana grow-house and research centre, which is considered the world’s largest.
According to BOL’s CEO Dr. Tamir Gedo, the company’s one-million-square-foot facility could store a volume of medical cannabis that could supply the entire U.S. BOL is capable of producing 80 tons (79,545 kilograms) on a yearly basis.
Furthermore, BOL is just one of the few companies in the world that can perform the CBD extraction process on a large scale.
Prepare to get rich
BOL’s IPO could fetch a US$1 billion valuation for the company. The decision to go public is because of the growing global demand for medical cannabis. BOL plans to export more than US$32 billion by 2028.
Better watch out for the ticker BOLP on the TSX soon. Breath of Life’s IPO could make you extremely rich.
The first wave of cannabis legalization minted millionaires out of everyday investors, and it might be about to happen again.
Because when edibles are legalized in Canada on October 17th, experts project a new $2.7 BILLION market will be born.
Our last legalization stock pick is already up 1,211%, and now we’re recommending one tiny small-cap stock before Cannabis 2.0.
This could be our next +1,000% winner in the cannabis space.
Hurry, the second wave of cannabis legalization is about to hit and this stock could skyrocket.
- Is it a Good Time to Buy This Cannabis Stock Valued at $1 Billion?
- 2 Cannabis Stocks to Buy and Hold for Decades
- RRSPs vs. TFSAs: 3 Key Differences
- Dividend Investors: Lock In This 11.7% Yield by September 19
- How to Make $400/Year in Passive Income on a $5,000 Investment
Fool contributor Christopher Liew has no position in any of the stocks mentioned.
Source: The Fool
Marijuana Stock Investors: Don’t Miss Out on This IPO